Philip Morris International Inc. logo

Philip Morris International Inc. (PM)

Market Closed
24 Feb, 20:00
NYSE NYSE
$
187. 00
-0.22
-0.12%
$
285.5B Market Cap
18.34 P/E Ratio
15.4% Div Yield
2,483,546 Volume
6.08 Eps
$ 187.22
Previous Close
Day Range
183.39 187.57
Year Range
142.11 190.98
Want to track PM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
PM earnings report is expected in 55 days (21 Apr 2026)
PM Grows Smoke-Free Profit Share: Will Margins Keep Expanding?

PM Grows Smoke-Free Profit Share: Will Margins Keep Expanding?

Philip Morris' smoke-free shift gained momentum in the first quarter of 2025 as high-margin products drove profit growth and strengthened its portfolio mix.

Zacks | 7 months ago
Philip Morris: Balanced Risk With Smoke-Free Transition

Philip Morris: Balanced Risk With Smoke-Free Transition

We initiate Philip Morris International Inc. at Hold with a $170 target, citing strong smoke-free momentum but stretched valuation versus peers. Operational execution—especially ZYN and IQOS scaling—drives above-consensus EPS forecasts, with cost savings and mix shift fueling margin expansion. Supply chain constraints and regulatory risks could cap upside, making capacity execution and policy developments key swing factors for the stock.

Seekingalpha | 7 months ago
Philip Morris: The Easy Money Has Been Made (Rating Downgrade)

Philip Morris: The Easy Money Has Been Made (Rating Downgrade)

Philip Morris has outperformed the market and tech giants over 5 years, driven by strong growth in smoke-free products like ZYN and IQOS. Despite impressive financial results and a successful smoke-free transition, I am downgrading my rating to neutral, due to limited upside and a lower dividend yield. PM now trades at a premium valuation with a sub-3% yield, making alternatives like MO, VZ, and growth stocks more attractive for new capital allocation.

Seekingalpha | 7 months ago
Philip Morris: ZYN And IQOS Are Killing The 'Tobacco Is Dead' Myth

Philip Morris: ZYN And IQOS Are Killing The 'Tobacco Is Dead' Myth

Philip Morris International's transformation to smoke-free products like ZYN and IQOS drives strong growth, higher margins, and outperformance, versus traditional tobacco peers. Despite a lower dividend yield than competitors, PM's capital appreciation and consistent dividend growth make it a superior long-term investment. Valuation is elevated at a 25.8x P/E, but justified by double-digit EPS growth, industry-leading profitability, and a future-proof product portfolio.

Seekingalpha | 7 months ago
Philip Morris' Valuation Looks Overstretched: Time to Hit Pause?

Philip Morris' Valuation Looks Overstretched: Time to Hit Pause?

PM's smoke-free pivot fuels a 50% rally, but its stretched valuation may signal a pause for investors.

Zacks | 8 months ago
2 Red-Hot Stocks Suited for Momentum Investors

2 Red-Hot Stocks Suited for Momentum Investors

Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions are present. And that's precisely what these companies have seen over recent months thanks to strong quarterly results.

Zacks | 8 months ago
Can Philip Morris Rely on Pricing to Drive 2025 EPS Growth?

Can Philip Morris Rely on Pricing to Drive 2025 EPS Growth?

Philip Morris International PM continues to lean on pricing as a key earnings driver. The company delivered a strong first quarter of 2025, with adjusted earnings per share (EPS) rising 12.7% year over year to $1.69.

Zacks | 8 months ago
Stocks rally on hopes Israel-Iran conflict will subside, Phillip Morris stock hits records

Stocks rally on hopes Israel-Iran conflict will subside, Phillip Morris stock hits records

Asking for a Trend anchor Josh Lipton breaks down the latest market trends for June 16, 2025. US stocks close higher on hopes the Israel-Iran conflict remains contained.

Youtube | 8 months ago
Bull of the Day: Philip Morris Intl (PM)

Bull of the Day: Philip Morris Intl (PM)

Philip Moriss is strategically evolving beyond its traditional cigarette business, exemplified by the remarkable success of its "Zyn" oral nicotine patch.

Zacks | 8 months ago
ZYN and IQOS Scale Up: Is Philip Morris Leading the Industry Reset?

ZYN and IQOS Scale Up: Is Philip Morris Leading the Industry Reset?

PM sees smoke-free products drive 44% of Q1 profit as ZYN and IQOS momentum redefines its future beyond tobacco.

Zacks | 8 months ago
Philip Morris Stock Records 50% YTD Surge: Is it Too Late to Buy?

Philip Morris Stock Records 50% YTD Surge: Is it Too Late to Buy?

PM stock soars 50.1% year to date, fueled by smoke-free growth, premium pricing and bullish earnings momentum.

Zacks | 8 months ago
Philip Morris International, Inc. (PM) dbAccess Global Consumer Conference Call Transcript

Philip Morris International, Inc. (PM) dbAccess Global Consumer Conference Call Transcript

Philip Morris International, Inc. (NYSE:PM ) dbAccess Global Consumer Conference Call June 3, 2025 5:15 AM ET Company Participants Emmanuel Babeau - CFO Conference Call Participants Damian McNeela - Deutsche Bank Damian McNeela Good morning, everybody. I think we will make a start.

Seekingalpha | 8 months ago
Loading...
Load More